Bristol-Myers Squibb to Present at William Blair Conference, Cancer Immunotherapy: A Long-Awaited Reality
Category:
Thursday, March 24, 2016 2:00 pm EDT
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will present at the William Blair Conference, Cancer Immunotherapy: A Long-Awaited Reality, on Thursday, March 31, 2016, in New York. Carl Decicco, senior vice president, Discovery, will make a formal presentation at 8:05 a.m. EDT.
Materials related to the presentation will be available at http://investor.bms.com. An archived edition of the presentation will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us onLinkedIn, Twitter, and YouTube.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.